Startseite › Prostatakrebs › Georgia › Atlanta
Klinische Studien zu Prostatakrebs in Atlanta, GA
33 Studien zu Prostatakrebs suchen Teilnehmer an Standorten in und um Atlanta (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Teilnehmer gesuchtPhase 3
- Northside Hospital, Atlanta
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Teilnehmer gesuchtPhase 1
- Emory University, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Atlanta VA Medical Center, Decatur · 6 mi entfernt
Addressing Health Literacy With a Tailored Survivorship Care Plan
Teilnehmer gesucht
- Grady Memorial Hospital, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Atlanta VA Medical Center, Atlanta
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Teilnehmer gesuchtPhase 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Teilnehmer gesuchtPhase 4
- Emory University, Atlanta
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Teilnehmer gesuchtPhase 1
- Emory University Winship Cancer Institute, Atlanta
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Teilnehmer gesuchtPhase 1
- Emory Winship Cancer Institute, Atlanta
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Teilnehmer gesuchtPhase 2/3
- Emory University, Atlanta
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Teilnehmer gesuchtPhase 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Teilnehmer gesuchtPhase 2
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi entfernt
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Teilnehmer gesuchtPhase 2
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi entfernt
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Teilnehmer gesuchtPhase 3
- Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
- Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Teilnehmer gesuchtPhase 3
- Grady Health System, Atlanta
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
- und 3 weitere
Prostate Active Surveillance Study
Teilnehmer gesuchtBeobachtungsstudie
- Emory University, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Teilnehmer gesuchtPhase 1
- Emory University - Winship Cancer Institute, Atlanta
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Teilnehmer gesuchtPhase 1
- Emory University, Atlanta
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Teilnehmer gesuchtPhase 1/2
- Emory University Hospital, Atlanta
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Teilnehmer gesuchtPhase 2
- Winship Cancer Institute, Emory University, Atlanta
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Emory University, Atlanta
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Teilnehmer gesuchtPhase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- und 3 weitere
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Teilnehmer gesuchtPhase 2
- Emory University Hospital, Atlanta
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Teilnehmer gesuchtBeobachtungsstudie
- Morehouse School of Medicine, Atlanta
- Emory Winship Cancer Institute, Atlanta
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Teilnehmer gesuchtPhase 1/2
- Emory University Hospital, Atlanta
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
Teilnehmer gesuchtPhase 2
- Emory University, Atlanta
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Teilnehmer gesuchtPhase 3
- Emory Proton Therapy Center, Atlanta
- Winship at Emory Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- und 1 weitere
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Teilnehmer gesuchtPhase 1/2
- Research Site, Atlanta
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
Teilnehmer gesucht
- Emory University Hospital/Winship Cancer Institute, Atlanta
Improving Health Literacy in African-American Prostate Cancer Patients
Teilnehmer gesucht
- Atlanta VA Medical Center, Atlanta
- Grady Memorial Hospital, Atlanta
- Emory University, Atlanta
- und 1 weitere
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Teilnehmer gesuchtPhase 1/2
- Emory University, Atlanta
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Research Site 114, Atlanta
- Research Site 139, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Atlanta
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Teilnehmer gesuchtPhase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- und 2 weitere
Prostatakrebs-Studien in anderen Städten
- New York City, NY103 Studien
- Houston, TX76 Studien
- Los Angeles, CA61 Studien
- Boston, MA59 Studien
- St. Louis, MO46 Studien
- Chicago, IL45 Studien
- San Francisco, CA45 Studien
- Philadelphia, PA44 Studien
- Baltimore, MD43 Studien
- Nashville, TN42 Studien
- Seattle, WA42 Studien
- Washington, DC38 Studien
Weitere Studien in Atlanta
- Krebs (alle Arten)49 Studien
- Nichtkleinzelliges Lungenkarzinom47 Studien
- Brustkrebs41 Studien
- Multiples Myelom41 Studien
- Akute myeloische Leukämie30 Studien
- Eierstockkrebs29 Studien
- Lungenkrebs29 Studien
- Kolorektales Karzinom29 Studien
- Metastasierender Krebs28 Studien
- Herzinsuffizienz25 Studien
- Major Depression25 Studien
- Plattenepithelkarzinom im Kopf-Hals-Bereich24 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.